A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies
Ontology highlight
ABSTRACT: STUDY OBJECTIVES
1. The primary objective of this protocol is to determine the safety of immunization with CEA(6D) VRP in patients with advanced or metastatic CEA expressing malignancies.
2. The secondary objectives are to evaluate CEA-specific immune response to the immunizations and obtain preliminary data on response rate.
DISEASE(S): Lung Cancer,Colon Cancer,Colorectal Cancer,Pancreatic Cancer,Breast Cancer,Neoplasms,Colonic Neoplasms
PROVIDER: 2044252 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA